Companies and Projects
Click on the names below to go to specific companies' own web sites
- Karus Therapeutics. I am a non-exec. director of Karus Therapeutics, a drug discovery start-up spun out from the University of Southampton.
- Glythera Ltd. . A spin-out from the University of Bath, developing new ways to improve protein-based drugs.
- The Iceni Seedcorn Fund A seed fund created under the UK Government's University Challenge Fund Scheme. I am a member of the advisory board to the fund.
- Rufus Scientific providing advice, planning and mentoring to new biotech start-ups
A few past projects
Amedis Pharmaceuticals |
Drug discovery company I founded in 1999/2000. Sold to Paradigm Therapeutics in 2005 |
Ark Therapeutics |
Wrote most of their Series A business plan (1997/8) and supported their Series B business plan and fundraising. Ark floated in in March 2004 |
Biovex |
Unlike a lot of those claiming credit for the recent $1bn exit of Biovex to Amgen, I actually was involved, helping write their Series A business plan in 1998/9 |
Delta G Ltd |
Therapeutics discovery company I founded in 2004. Company closed down in 2008. |
Opal Drug Discovery |
Therapeutics discovery company I co-founded in 2006. We are now dormant, but Opal may rise again! |
Vectura |
Wrote much the Series A business plan for this drug delivery technology company in 1998. Company subsequently floated on AIM in 2004 |